(Q34172937)

31 July 2017

title

Adult coeliac patients do tolerate large amounts of oats (English)

1 reference

31 July 2017

Størsrud S

1

1 reference

31 July 2017

Olsson M

2

1 reference

31 July 2017

Arvidsson Lenner R

3

1 reference

31 July 2017

Nilsson LA

4

1 reference

31 July 2017

Nilsson O

5

1 reference

31 July 2017

Kilander A

6

1 reference

31 July 2017

publication date

1 January 2003

1 reference

European Journal of Clinical Nutrition

31 July 2017

published in

1 reference

31 July 2017

volume

57

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

163-169

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.ejcn.1601525

31 July 2017

exact match

0 references

cites work

Oats and barley toxicity in coeliac patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601525

Dose dependent effects of protracted ingestion of small amounts of gliadin in coeliac disease children: a clinical and jejunal morphometric study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601525

Wheat starch intolerance in patients with celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601525

In vitro assessment of acetic-acid-soluble proteins (glutenin) toxicity in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601525

Coeliac disease. II. The presence in wheat of a factor having a deleterious effect in cases of coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601525

Malignancy in coeliac disease--effect of a gluten free diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601525

A comparison of diets with and without oats in adults with celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601525

Lack of cellular and humoral immunological responses to oats in adults with coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601525

No harm from five year ingestion of oats in coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601525

The teenage coeliac: follow up study of 102 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601525

Gastrointestinal symptoms rating scale in coeliac disease patients on wheat starch-based gluten-free diets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601525

Compliance of adolescents with coeliac disease with a gluten free diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601525

The place of oats in the coeliac diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601525

Tolerance to oats in dermatitis herpetiformis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601525

Oat products and lipid lowering. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601525

Lack of oats toxicity in coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601525

Persistent mucosal abnormalities in coeliac disease are not related to the ingestion of trace amounts of gluten

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601525

Absence of oats toxicity in adult coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601525

Do oats belong in a gluten-free diet?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601525

Reversal of osteopenia with diet in adult coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601525

The precipitating factor in coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601525

Value of serologic markers for clinical diagnosis and population studies of coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601525

7 January 2021

Characterization of the gliadin-derived peptides which are biologically active in coeliac disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601525

7 January 2021

Absence of toxicity of oats in patients with dermatitis herpetiformis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601525

7 January 2021

Wheat starch-containing gluten-free flour products in the treatment of coeliac disease and dermatitis herpetiformis. A long-term follow-up study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601525

7 January 2021

Evaluation of gliadin antibodies for detection of coeliac disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601525

7 January 2021

Serum IgA and IgG gliadin antibodies and small intestinal mucosal damage in children.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601525

7 January 2021

Immunologic evidence of no harmful effect of oats in celiac disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601525

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601525

1 reference

7 January 2021

Identifiers

DOI

10.1038/SJ.EJCN.1601525

1 reference

Dimensions Publication ID

31 July 2017

1038522123

0 references

1 reference